SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-24-064405
Filing Date
2024-03-11
Accepted
2024-03-11 09:01:59
Documents
16
Period of Report
2024-03-11
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d737752d8k.htm   iXBRL 8-K 24991
2 EX-99.1 d737752dex991.htm EX-99.1 19579
6 GRAPHIC g737752g0311043416995.jpg GRAPHIC 4263
  Complete submission text file 0001193125-24-064405.txt   179355

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA vtyx-20240311.xsd EX-101.SCH 2844
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE vtyx-20240311_lab.xml EX-101.LAB 17994
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE vtyx-20240311_pre.xml EX-101.PRE 11257
17 EXTRACTED XBRL INSTANCE DOCUMENT d737752d8k_htm.xml XML 3642
Mailing Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130
Business Address 12790 EL CAMINO REAL, SUITE 200 SAN DIEGO CA 92130 (858) 945-2393
Ventyx Biosciences, Inc. (Filer) CIK: 0001851194 (see all company filings)

IRS No.: 832996852 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-40928 | Film No.: 24736720
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)